Amazing #ISLB24 congress in summary:
303 participants,
24 countries 🌎
100 abstracts 📝
50 speakers 👨‍🏫👩‍🏫
26 travel awards ✈️
3 ISLB awards🥇
32 sponsors
5 satellite symposium ✏️
THAKS ALL OF YOU “THE” INTERNATIONAL LIQUID BIOPSY SOCIETY IS GROWING EVERY YEAR ! @isliquidbiopsy

🌟 A growing society, a brighter future!
📍 Denver welcomed 303 delegates from 24 countries, 100 abstracts, and 76 posters at #ISLB24.
See you in Orlando for #ISLB25!
#LiquidBiopsy #Oncology #PrecisionMedicine
@christianrolfo.bsky.social
@rolfolab.bsky.social
@oncoalert.bsky.social

It has been an amazing #ISLB24 congress!! More than 300 participants from 24 countries around the globe 🌎 50 speakers and more than 100 abstracts with 24 travel grants. Great discussions! Thanks to participants, speakers, sponsors & @ICS_Events ! See you in Orlando #ISLB25 !

@GianniNigita from @osucccjames.bsky.social @rolfolab.bsky.social presenting the minimal requirements for bioinformatics in analyzing liquid biopsy data at #ISLB24

More complex data —> more power bioinformatics required! 💻🤖

@christianrolfo.bsky.social @UmbertoMalapel1 @isliquidbiopsy

One of the best slides of #ISLB24! Molecular testing transforms cancer care—from early detection to resistance mechanisms in metastatic disease. Precision at every stage.
@drgandara
@christianrolfo.bsky.social @oncoalert.bsky.social

Honored to have @lillian_siu elected president of @AACR at the #ISLB24 meeting talking about HPV ctDNA!

HPV genotyping in plasma may be the future!

Truly inspiring 💪🏻🔥🎯

@isliquidbiopsy
@christianrolfo.bsky.social
@christianrolfo.bsky.social
@UmbertoMalapel1

High ctDNA tumor fraction boosts confidence in driver-negative reports, while low ctDNA suggests need for confirmatory tissue testing.
#LiquidBiopsy #Oncology #PrecisionMedicine #ISLB24
@christianrolfo.bsky.social @oncoalert.bsky.social

Great panel discussion on the session about early cancer detection at #ISLB24

So many options and ideas for cancer research! 🎯🔍

@christianrolfo.bsky.social
#JacobBerchuck
#trevorPugh
#martaDuenas

@internationalsocietyofliquidbiopsy

@christianrolfo.bsky.social presenting at #ISLB24 early detection strategies for different cancers!
📚Many studies are being published in this topic

What is the best strategy?
—>a mix of different technologies 👨🏻‍🔬👩‍🔬 + AI integration! 🤖

@isliquidbiopsy
@OSUCCC_James

Second day at #ISLB24 with @christianrolfo.bsky.social presenting data on early cancer detection in different cancer types!

—> is possible but there are many different LB 🩸 method that must be integrated with AI 🤖

@internationalsocietyofliquidbiopsy
@ohiostatepress.bsky.social

ISLB committees are tirelessly working to shape a better future for patients and society. Advancing innovation and collaboration in liquid biopsy!

#LiquidBiopsy #Oncology #PrecisionMedicine #ISLB24 @christianrolfo.bsky.social @oncoalert.bsky.social

🏆Award session and inspiring Award lectures!
#LuisDiaz #EllenHeltzer #DennisLo

#ISLB24

@isliquidbiopsy @christianrolfo.bsky.social @MJOSESERRANO19

🎯 @BrunaPellini just explained to me how their algorithm could help in distinguishing between variants identified via LB “truly/potentially” targetable vs CH-derived across different tumor types

⚡️ Great energy here! @isliquidbiopsy

#ISLB24

Luis Diaz’s award lecture emphasized liquid biopsy’s role in precision medicine: biomarkers, tumor monitoring, resistance tracking, and early detection.

#LiquidBiopsy #Oncology #ISLB24 @christianrolfo.bsky.social
@oncoalert.bsky.social

❔❓Having expert to discuss key questions in liquid biopsy!

This is #ISLB24

@isliquidbiopsy @christianrolfo.bsky.social
#abhijitPatel #pazVellanki #murryWynes #davidkozono #lucaQuagliata #adamSowalsky

Great job by @Rparedes_MD presenting our poster on “ctDNA as marker for Brain Metastasis at Diagnosis and During Treatment” at #ISLB24 @rolfolab

@isliquidbiopsy @OhioStateMedOnc @OSUCCC_James @IcahnMountSinai @TischCancer

LB - Tissue

Detection of gene copy number (CN) losses (PTEN, BRCA1/2, PALB2) in prostate, breast and ovarian cancer.

--> High concordance (liquid/tissue) in samples with Tumor Fraction ≥ 20% (sensitivity 83%)

#ISLB24
@christianrolfo.bsky.social
@internationalsocietyofliquidbiopsy

Super poster session! 🧨
@UmbertoMalapel1
shows us how an algorithm can filter out genomic alterations while analyzing LB sample in a prostate cancer cohort of patients!

#ISLB24

@isliquidbiopsyx.com/RobertoBoreaMD/status/18...

Collaboration and innovation at #ISLB24! Connecting with brilliant minds to advance the field of #LiquidBiopsy and #PrecisionMedicine. Together, we push boundaries.
@oncoalert.bsky.social
@christianrolfo.bsky.social

At #ISLB24 release of the new @oncoindx multiomics machine on Live Single CTCs combining genomic profiling with CTC DNA and ctDNA 🧬

@christianrolfo.bsky.social

Terrific presentation of @christianrolfo.bsky.social from @OSUCCC_James on tumor fraction detection and calculation in cfDNA! 🧬

—> we must implement cfDNA fraction analysis to improve the comprehension of LB

#ISLB24

@internationalsocietyofliquidbiopsy
@UmbertoMalapel1 @stoverlab.bsky.social

Can we trust negative ctDNA results? @christianrolfo.bsky.social
🧬🩸Data from #ISLB24 highlights the prognostic value of tumor fraction in ctDNA.
🧬🩸Tumor fraction ≥1% correlates strongly with actionable findings, while low TF (<1%) often requires tissue-based confirmation for accuracy.

Great presentation from @natashaleighl from @pmargaretcancercenter on the usage of molecular testing in cancer patients!

🥵 Hot topics:
- timing ⏱️
- patient point of view 🫵
- type of test 🤷🏻‍♀️
- cost 💰

#ISLB24

Liquid biopsies improve testing rates, reduce delays, and guide optimal treatment in advanced lung cancer. Making it routine is the next big step. #ISLB24

#LiquidBiopsy #Oncology
@christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social

LB 🩸 isn’t only for medical oncologist!
@aadel_chaudhuri from @MayoClinic is sharing data on the use of LB MRD during and after radiotherapy treatment with great results in predicting patient outcome!

#ISLB24

@christianrolfo.bsky.social @rolfolab.bsky.social
@isliquidbiopsy

We are all genetic mosaics! Clonal mosaicism is the rule, not the exception. A fascinating insight into our cellular diversity at #ISLB24.

#LiquidBiopsy #Oncology
@christianrolfo.bsky.social
@rolfolab.bsky.social
@oncoalert.bsky.social

cfDNA analysis is a cornerstone of precision oncology. Serial liquid biopsies hold promise for urothelial and prostate cancers. Future directions shared at #ISLB24.

#LiquidBiopsy #Oncology
@christianrolfo.bsky.social
@oncoalert.bsky.social

Nice to meet great international colleagues/researchers at #ISLB24! 🌎

Ready for this great event to share knowledge about liquid biopsy! 🔥

@internationalsocietyofnliquidbiopsy
@christianrolfo.bsky.social
@umbertomalapelle
@brunapellini
@robertoboreamd.bsky.social
@mariantonianacchio

David R. Gandara discusses recent applications of ctDNA in early-stage NSCLC at #ISLB24. Liquid biopsy is transforming precision treatment strategies.
🩸🧬Is MRD testing ready for routine use?
#LiquidBiopsy #Oncology
@christianrolfo.bsky.social
@oncoalert.bsky.social

20 years of advancements in circulating tumor cells. From discovery to clinical utility in solid tumors, transforming breast cancer management at #ISLB24.
#LiquidBiopsy #Oncology @christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social